fenfluramine and urea
fenfluramine has been researched along with urea in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Förster, H; Huth, K; Koch, E; Tunali, G | 1 |
| Aust, L; Boschmann, M; Frenz, U; Noack, R | 1 |
| Bonhaus, DW; McFarland, K; Price, DL | 1 |
Other Studies
3 other study(ies) available for fenfluramine and urea
| Article | Year |
|---|---|
[Is fenfluramine suitable as a therapeutic principle in obese aged diabetics? (end)].
Topics: Aged; Cholesterol; Diabetes Mellitus; Fenfluramine; Gastric Emptying; Glucose; Humans; Lactates; Obesity; Urea | 1979 |
Energy expenditure and substrate oxidation rates of obese rats during a 12-day treatment with dexfenfluramine.
Topics: Amino Acids; Animals; Blood Glucose; Body Weight; Calorimetry, Indirect; Dose-Response Relationship, Drug; Eating; Energy Metabolism; Fatty Acids, Nonesterified; Fenfluramine; Glycogen; Insulin; Liver; Male; Muscle, Skeletal; Obesity; Oxidation-Reduction; Pyruvate Kinase; Rats; Rats, Wistar; Serotonin Receptor Agonists; Urea | 1996 |
Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease.
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Dyskinesias; Fenfluramine; Fluorobenzenes; Hyperkinesis; Male; Motor Activity; Oxidopamine; Parkinson Disease; Piperidines; Psychotic Disorders; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Sensory Gating; Serotonin 5-HT2 Receptor Antagonists; Serotonin Agents; Serotonin Receptor Agonists; Substantia Nigra; Tyrosine 3-Monooxygenase; Urea | 2011 |